NEULANDLAB23,800.00

Neuland Laboratories Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABLAURUSLABSNHNATCOPHARMLALPATHLABSAILIFECOHANCEASTERDMMcap ₹30,703 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment522.7673.7892.3892.3
+ Capital Work-in-Progress45.944.6209.5209.5
+ Investment Property19.00.00.00.0
+ Goodwill279.5279.5279.5279.5
+ Other Intangibles2.51.75.25.2
+ Intangibles under Development0.03.11.11.1
+ Non-current Investments1.31.52.02.0
+ Other Non-current Financial Assets8.59.411.911.9
Non-current Financial Assets9.710.913.913.9
+ Deferred Tax Assets0.011.30.00.0
+ Other Non-current Assets32.215.645.645.6
Total Non-current Assets911.51,040.41,447.01,447.0
Current Assets
+ Inventories350.4385.8510.3510.3
+ Current Investments0.0107.70.00.0
+ Trade Receivables373.5315.7541.4541.4
+ Cash & Cash Equivalents87.6131.976.776.7
+ Other Bank Balances29.2126.9278.3278.3
+ Other Current Financial Assets2.92.24.34.3
Current Financial Assets493.2684.4900.7900.7
+ Other Current Assets77.469.372.272.2
Total Current Assets921.11,139.51,483.11,483.1
Total Assets1,832.62,179.92,930.12,930.1
Equity
+ Equity Share Capital12.912.912.912.9
+ Other Equity / Reserves1,269.81,511.91,861.61,861.6
Equity — Owners of Parent1,282.71,524.81,874.51,874.5
Total Equity1,282.71,524.81,874.51,874.5
Liabilities
+ Borrowings — Non-current44.990.7160.9160.9
+ Other Non-current Financial Liab9.218.699.799.7
Non-current Financial Liabilities54.1109.3260.6260.6
+ Provisions — Non-current7.67.215.915.9
+ Deferred Tax Liabilities60.472.869.069.0
Non-current Liabilities122.2189.4345.5345.5
+ Borrowings — Current37.645.335.735.7
+ Trade Payables192.0252.2269.1269.1
+ Other Current Financial Liab110.387.1131.7131.7
Current Financial Liabilities339.8384.5436.6436.6
+ Provisions — Current1.62.12.32.3
+ Current Tax Liabilities0.10.118.218.2
+ Other Current Liabilities86.179.0253.2253.2
Current Liabilities427.7465.7710.2710.2
Total Liabilities549.9655.11,055.71,055.7
Total Equity & Liabilities1,832.62,179.92,930.12,930.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current8.412.612.6
+ Dues to Other Creditors — Current243.8256.5256.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.